GlassScriptPhysician profile
Emelia Dede Winston
NPI 1922486885
$2,287.31
in general payments reported to CMS, 2019-2025
30 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $512 · 2021: $464 · 2022: $681 · 2023: $265 · 2024: $108 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.29 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $273.88 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Ethicon US, LLC | $258.91 | 2021-2025 | Enseal, Harmonic |
| Hologic Sales and Service, LLC | $246.01 | 2020-2023 | Coolseal Generator, Acessa Provu System |
| Medical Device Business Services, INC. | $225.41 | 2021-2022 | |
| Gynesonics, INC. | $201.63 | 2022 | |
| Glaxosmithkline, LLC. | $196.81 | 2020 | |
| Coopersurgical, INC. | $128.59 | 2020-2023 | Summit Doppler, Paragard T 380a |
| Astellas Pharma US INC | $68.66 | 2024 | Veozah |
| Applied Medical Resources Corporation | $66.30 | 2022 | |
| Aspira Women'S Health INC | $57.37 | 2021-2024 | Ova1 |
| Merck Sharp & Dohme LLC | $45.57 | 2019 | |
| Organon LLC | $42.01 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.40 | 2021-2022 | |
| Therapeuticsmd, INC. | $40.06 | 2022 | |
| Davol INC. | $36.15 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36.04 | 2022 | |
| Channel Medsystems, INC. | $34.81 | 2022-2023 | |
| Myovant Sciences INC. | $34.15 | 2021 | |
| Pfizer INC. | $32.19 | 2023 | |
| Baxter Healthcare | $32.10 | 2024 | Perclot |
| Myriad Women'S Health, INC. | $31.64 | 2023 | Myrisk |
| Mayne Pharma Commercial LLC | $30.14 | 2023 | |
| Lupin INC. | $27.56 | 2020-2021 | |
| Exact Sciences Corporation | $22.09 | 2023 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $15.23 | 2021 | |
| Meditrina | $13.75 | 2023 | |
| Exeltis, USA INC. | $12.97 | 2021 | |
| Avion Pharmaceuticals | $12.83 | 2021 | |
| Amgen INC. | $12.81 | 2022 | |
| Novo Nordisk INC | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emelia Winston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.